Peer Review reports
From: Clinical markers of immunotherapy outcomes in advanced sarcoma
| Original Submission | ||
|---|---|---|
| 18 Oct 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 13 Dec 2022 | Reviewed | Reviewer Report - Sameer Rastogi |
| 26 Dec 2022 | Reviewed | Reviewer Report |
| 10 Jan 2023 | Author responded | Author comments - Gabriel Tinoco |
| Resubmission - Version 4 | ||
| 10 Jan 2023 | Submitted | Manuscript version 4 |
| 17 Jan 2023 | Author responded | Author comments - Gabriel Tinoco |
| Resubmission - Version 5 | ||
| 17 Jan 2023 | Submitted | Manuscript version 5 |
| 18 Jan 2023 | Author responded | Author comments - Gabriel Tinoco |
| Resubmission - Version 6 | ||
| 18 Jan 2023 | Submitted | Manuscript version 6 |
| 13 Feb 2023 | Reviewed | Reviewer Report |
| 9 Mar 2023 | Author responded | Author comments - Gabriel Tinoco |
| Resubmission - Version 7 | ||
| 9 Mar 2023 | Submitted | Manuscript version 7 |
| 21 Mar 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 21 Mar 2023 | Editorially accepted | |
| 7 Apr 2023 | Article published | 10.1186/s12885-023-10758-w |
You can find further information about peer review here.